Navigation Links
Sunpeaks Ventures Signs Advertising and Promotion Agreement With Another Major Sports Team - Clotamin To Be Sold at All Walgreens Locations Throughout Arizona

SILVER SPRING, Md., April 13, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has entered into an advertising and promotion agreement ("Agreement") with a major pro sports team based in the state of Arizona (the "Team") for the marketing of Clotamin.  The Agreement is part of new marketing initiatives to promote and launch Clotamin in 240 Walgreens throughout Arizona.

Under terms of the Agreement, HDS, in conjunction with Walgreens, will have the right to make use of the Team name and logo in connection with an in-store Clotamin promotion, including the prominent placement of counter point-of-sale (POS) displays in all Walgreens locations in the state of Arizona for the duration of the promotion – approximately five months, beginning on June 1, 2012. 

During the consumer promotion and advertising program, Clotamin will be featured at Team home games on signage and other marketing elements throughout the University of Phoenix Stadium in Glendale, Arizona.  Team fans will be encouraged to visit their local Walgreens location, pick-up an entry form at the Team vendor display, and register for the opportunity to experience a Team home game in the comfort of an exclusive private box.  One lucky winner each month (4 total) will receive a private box for a Team home game, including game tickets, VIP parking passes, and a food and beverage package for 16 guests.  Also included in the exclusive prize package experience is special personal appearance by the Team mascot/cheerleaders and 16 team gift bags. 

"Similar to our pro sports team deal to market Clotamin with Walgreens in Oregon, this new agreement in Arizona is designed to leverage our advertising capabilities to grow awareness and acceptance of Clotamin with strong endorsements and strategic sponsorships," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "The marketing combination of pharmacy powerhouse Walgreens and a highly-recognizable pro sports team is designed to allow us to quickly introduce Clotamin to a statewide audience of loyal customers and fans.  We look forward to working closely with Walgreens and the Team to make this a successful product launch and an unforgettable experience for our contest winners."

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market.   HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit

Contact: Financial Insights 888-248-8491 or

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.  The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements.  These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements.  The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission.  All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement.  Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.

SOURCE Sunpeaks Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Enters Agreement with UK Based Healthcare Firm to Introduce Clotamin to UK and European Union Countries
2. Sunpeaks Ventures Announces Letter of Intent to Export Clotamin to Top Russian Pharmacies
3. Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
4. Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
5. Sunpeaks Ventures Announces Agreement with Albeck Financial Services
6. Sunpeaks Ventures Announces Clotamin to Be Sold at Winn-Dixie Locations in South Florida
7. Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida
8. Sunpeaks Ventures to Participate in ECRM Conference and Expo
9. Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies
10. Sunpeaks Ventures Announces Clotamin available on
11. Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector
Post Your Comments:
(Date:11/24/2015)... 24, 2015  Freudenberg Medical has developed specialty tubing for ... of medical facilities. Africa and ... is sparse. Nevertheless, prompt diagnosis is important to treat those ... virus. With the help of a portable mini-lab or "lab ... village in affected areas and perform rapid testing for HIV. ...
(Date:11/24/2015)... November 24, 2015 Edelris announce today ... co-own with Inserm, Poxel, CNRS, UCBL and ENS-Lyon on a ... --> Hepatitis B virus (HBV) infection is ... people chronically infected worldwide, 20 to 40% of them being ... carcinoma. Despite the existence of an effective preventive vaccine, the ...
(Date:11/24/2015)... Ill. , Nov. 24, 2015  Wellness Center USA ... November shipments of its flagship product, Psoria-Light® (PL 1000), to targeted dermatology ... Houston, Minnesota , and North Carolina ... Cleveland , Chicago , and ... --> Revenue for the earlier shipments reported on October ...
Breaking Medicine Technology:
(Date:11/24/2015)... FL (PRWEB) , ... November 24, 2015 , ... In ... a growing epidemic as deaths from prescription opioids in the United States grew 400 ... cocaine. In 2013 alone, opioids were involved in 37 percent of all fatal drug ...
(Date:11/24/2015)... ... , ... Serenity Point Rehabilitation, a holistic treatment center for substance abuse located ... the staff members at their recovery center. The videos highlight some of the various ... the things that make their recovery program so unique. , “Making the decision to ...
(Date:11/24/2015)... ... November 24, 2015 , ... Chiropractic student Katie Benson received ... in Overland Park, Kansas. Benson, a fifth-trimester student in the university’s College of ... on October 16. , “Katie is very excited and greatly appreciative to receive ...
(Date:11/24/2015)... ... November 24, 2015 , ... Autism Speaks, the world’s leading autism science ... social media and the generosity of people around the world. On December 1, supporters ... to give – and share the personal stories behind those gifts. , Just ...
(Date:11/24/2015)... IL (PRWEB) , ... November 24, 2015 , ... ... and engineer of patented products, announces Fragrance by Marcelle, a cosmetic invention which ... The Perfume & Fragrance Manufacturing Market in the US is worth $3 billion ...
Breaking Medicine News(10 mins):